Oxnard cannabis technology company Cure Pharmaceutical announced an initial bid to acquire Coeptis Pharmaceuticals, a maker of arthritis and high blood pressure treatments. Cure, which makes a thin dissolvable strip for oral drug delivery, announced Nov. 14 that it had purchased $200,000 in convertible promissory notes for Coeptis, a first step in a bid to…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
